Bhushan S Pattni - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Bhushan S Pattni

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Advanced Drug Delivery Reviews|August 27, 2013

Nanopreparations to overcome multidrug resistance in cancerNiravkumar R Patel, Bhushan S Pattni, Abraham H Abouzeid, et al.

International Journal of Pharmaceutics|August 29, 2017

Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DGBhushan S Pattni, Aditi Jhaveri, Ivy Dutta, et al.

Pharmaceutical Research|June 29, 2016

Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid ModelBhushan S Pattni, Srikar G Nagelli, Bhawani Aryasomayajula, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Advanced Drug Delivery Reviews|August 27, 2013

Nanopreparations to overcome multidrug resistance in cancerNiravkumar R Patel, Bhushan S Pattni, Abraham H Abouzeid, et al.

International Journal of Pharmaceutics|August 29, 2017

Targeting energy metabolism of cancer cells: Combined administration of NCL-240 and 2-DGBhushan S Pattni, Aditi Jhaveri, Ivy Dutta, et al.

Pharmaceutical Research|June 29, 2016

Targeting of Micelles and Liposomes Loaded with the Pro-Apoptotic Drug, NCL-240, into NCI/ADR-RES Cells in a 3D Spheroid ModelBhushan S Pattni, Srikar G Nagelli, Bhawani Aryasomayajula, et al.

Pageof 1